---
title: "If You Invested $100 In BeOne Medicines Stock 10 Years Ago, You Would Have This Much Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305882088.md"
description: "BeOne Medicines (NASDAQ:ONC) has outperformed the market over the past decade with an annualized return of 29.37%, surpassing the market by 16.62%. A $100 investment made ten years ago would now be worth $1,311.52, based on a current stock price of $412.86 and a market capitalization of $46.53 billion. The article highlights the power of compounded returns on cash growth."
datetime: "2026-11-17T22:00:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305882088.md)
  - [en](https://longbridge.com/en/news/305882088.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305882088.md)
generator: "portal-rs"
---

# If You Invested $100 In BeOne Medicines Stock 10 Years Ago, You Would Have This Much Today

BeOne Medicines (NASDAQ:ONC) has outperformed the market over the past 10 years by 16.62% on an annualized basis producing an average annual return of 29.37%. Currently, BeOne Medicines has a market capitalization of $46.53 billion.

**Buying $100 In ONC:** If an investor had bought $100 of ONC stock 10 years ago, it would be worth **$1,311.52** today based on a price of $412.86 for ONC at the time of writing.

### BeOne Medicines’s Performance Over Last 10 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/11/17/3a99c0b1871c4cd68a1f5912ac57d892.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

*This article was generated by Benzinga's automated content engine and reviewed by an editor.*

### Related Stocks

- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)

## Related News & Research

- [BeOne Medicines: Five solid-tumor programs advance as strong cash flow funds continued pipeline investment](https://longbridge.com/en/news/305810947.md)
- [BeOne Medicines Ltd. - Sponsored ADR $ONC Position Trimmed by Crossmark Global Holdings Inc.](https://longbridge.com/en/news/302981101.md)
- [ANALYSIS-Anthropic listing extends Nasdaq's dominant run against arch-rival NYSE](https://longbridge.com/en/news/306184666.md)
- [Destiny Tech100 Stock Slips as Anthropic Launches Record IPO](https://longbridge.com/en/news/306147806.md)
- [Securitize Tokenizes Anthropic Stock Onchain on First Day of Public Trading | ANT Stock News](https://longbridge.com/en/news/306158867.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**